@prefix dcterms: .
@prefix dgn-np: .
@prefix this: .
@prefix rdfs: .
@prefix xsd: .
@prefix sio: .
@prefix ncit: .
@prefix lld: .
@prefix miriam-gene: .
@prefix miriam-pubmed: .
@prefix eco: .
@prefix wi: .
@prefix prov: .
@prefix pav: .
@prefix prv: .
@prefix np: .
@prefix dgn-gda: .
@prefix dgn-void: .
dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_head {
this: np:hasAssertion dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_assertion;
np:hasProvenance dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_provenance;
np:hasPublicationInfo dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_publicationInfo;
a np:Nanopublication .
dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_assertion a np:Assertion .
dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_provenance a np:Provenance .
dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_publicationInfo
a np:PublicationInfo .
}
dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_assertion {
miriam-gene:2064 a ncit:C16612 .
lld:C0001418 a ncit:C7057 .
dgn-gda:DGN8dfce5de42eecfcc1ce5b593f4a6cefb sio:SIO_000628 miriam-gene:2064, lld:C0001418;
a sio:SIO_001121 .
}
dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_provenance {
dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_assertion dcterms:description
"[Among the findings: peptic ulcer disease is a significant predisposing risk factor (odds ratio = 3.9) for pancreatic cancer; as many as 50% of all intraductal papillary mucinous neoplasms are associated with invasive adenocarcinomas; alteration of gene expression via methylation of a gene promotor region constitutes a potentially reversible method of tumor suppressor gene inactivation; > 400 transcriptional alterations of gene expression have been identified for pancreatic cancer; some common molecular markers such as p53 and HER-2/neu may be related to morphologic alterations of in situ neoplasia and to transcriptional alterations of gene expression rather than mutational events; epidermal growth factor (EGF), transforming growth factor beta (TGF-beta), and related molecules may modulate gene transcription via autocrine or paracrine mechanisms; several cytokines, amylin (islet amyloid polypeptide), and other cachexia factors are responsible for paraneoplastic peripheral insulin resistance, ineffective utilization of glucose, and profound cachexia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en;
wi:evidence dgn-void:source_evidence_literature;
sio:SIO_000772 miriam-pubmed:9821173;
prov:wasDerivedFrom dgn-void:befree-2016;
prov:wasGeneratedBy eco:ECO_0000203 .
dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date .
dgn-void:source_evidence_literature a eco:ECO_0000212;
rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en;
rdfs:label "DisGeNET evidence - LITERATURE"@en .
}
dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_publicationInfo {
this: dcterms:created "2016-05-13T12:52:25+02:00"^^xsd:dateTime;
dcterms:rights ;
dcterms:rightsHolder dgn-void:IBIGroup;
dcterms:subject sio:SIO_000983;
prv:usedData dgn-void:disgenetv3.0rdf;
pav:authoredBy , ,
, , ;
pav:createdBy ;
pav:version "v4.0.0.0" .
dgn-void:disgenetv3.0rdf pav:version "v4.0.0" .
}